Osteoporosis, inflammation and ageing

被引：317

作者：

Ginaldi L. ^{[1
]}

Di Benedetto M.C. ^{[1
]}

De Martinis M. ^{[1
]}

机构：

[1] Department of Internal Medicine, University of L'Aquila, L'Aquila

来源：

Immunity & Ageing | / 2卷 / 1期

关键词：

Ageing; Bone remodelling; Cytokines; Inflammation; Osteoporosis;

D O I：

10.1186/1742-4933-2-14

中图分类号：

学科分类号：

摘要：

Osteoporosis is a condition characterized by low bone mass and increased bone fragility, putting patients at risk of fractures, which are major causes of morbidity substantially in older people. Osteoporosis is currently attributed to various endocrine, metabolic and mechanical factors. However, emerging clinical and molecular evidence suggests that inflammation also exerts significant influence on bone turnover, inducing osteoporosis. Numerous proinflammatory cytokines have been implicated in the regulation of osteoblasts and osteoclasts, and a shift towards an activated immune profile has been hypothesized as important risk factor. Chronic inflammation and the immune system remodelling characteristic of ageing, as well as of other pathological conditions commonly associated with osteoporosis, may be determinant pathogenetic factors. The present article will review the current perspectives on the interaction between bone and immune system in the elderly, providing an interpretation of osteoporosis in the light of inflamm-ageing. © 2005 Ginaldi et al; licensee BioMed Central Ltd.

引用

共 54 条

[1]

Delmas P.D., Treatment of postmenopausal osteoporosis, Lancet, 359, pp. 2018-2026, (2002)

[2]

Yun A.J., Lee P.Y., Maladaptation of the link between inflammation and bone turnover may be a key determinant of osteoporosis, Med Hypotheses, 63, pp. 532-537, (2004)

[3]

Arron J.R., Choi Y., Bone versus immune system, Nature, 408, pp. 535-536, (2000)

[4]

Lorenzo J., Interactions between immune and bone cells: New insights with many remaining questions, J Clin Invest, 106, pp. 749-752, (2000)

[5]

Mitra D., Elvins D.M., Speden D.J., Collins A.J., The prevalence of vertebral fractures in mild ankylosing spondylitis and their relationship to bone mineral density, Rheumatology, 39, pp. 85-89, (2000)

[6]

Haugeberg G., Lodder M.C., Lems W.F., Uhlig T., Orstavik R.E., Dijkmans B.A., Kvien T.K., Woolf A.D., Hand cortical bone mass and its associations with radiographic joint damage and fractures in 50-70 year old female patients with rheumatoid arthritis: Cross sectional Oslo-Truro-Amsterdam (OSTRA) collaborative study, Ann Rheum Dis, 63, pp. 1331-1334, (2004)

[7]

Bultink I.E., Lems W.F., Kostense P.J., Dijkmans B.A., Voskuyl A.E., Prevalence of and risk factors for low bone mineral density and vertebral fractures in patients with systemic lupus erythematosus, Arthritis Rheum, 52, pp. 2044-2050, (2005)

[8]

Mikuls T.R., Saag K.G., Curtis J., Bridges Jr. S.L., Alarcon G.S., Westfall A.O., Lim S.S., Smith E.A., Jonas B.L., Moreland L.W., CLEAR investigators: Prevalence of osteoporosis and osteopenia among African Americans with early rheumatoid arthritis: The impact of ethnic-specific normative data, J Natl Med Assoc, 97, pp. 1155-1160, (2005)

[9]

Walsh N.C., Gravallese E.M., Bone loss in inflammatory arthritis: Mechanisms and treatment strategies, Curr Opin Rheumatol, 16, pp. 419-427, (2004)

[10]

Annapoorna N., Rao G.V., Reddy N.S., Rambabu P., Rao K.R., An increased risk of osteoporosis during acquired immunodeficiency syndrome, Int J Med Sci, 1, pp. 152-164, (2004)

← 1 2 3 4 5 6 →